felin
infecti
periton
viru
fipv
coronavirida
caus
lethal
viral
infect
cat
fip
relat
felin
enter
coronaviru
fecv
caus
mild
enter
felin
coronavirus
manifest
differ
vivo
known
studi
infect
kinet
titr
antigen
express
fipv
fecv
determin
peripher
blood
monocyt
donor
cat
compar
crandel
felin
kidney
crfk
cell
infect
kinet
monocyt
host
depend
monocyt
cat
resist
fipvand
fecvinfect
monocyt
cat
could
initi
infect
fipv
fecv
fipv
infect
sustain
monocyt
one
cat
fecvinfect
never
sustain
viral
product
time
lower
fipvinfect
monocyt
crfk
cell
fipv
fecv
infect
kinet
differ
monocyt
larger
cat
popul
n
infect
pattern
also
found
consid
investig
cat
suscept
fipv
fecv
rest
could
infect
fecv
fipv
cat
monocyt
sustain
fipv
infect
sustain
neither
fipv
fecv
infect
author
contribut
equal
two
coronavirus
describ
cat
felin
infecti
periton
viru
fipv
felin
enter
coronaviru
fecv
felin
coronavirus
spread
worldwid
infect
cat
member
famili
felida
infect
fecv
usual
subclin
except
young
kitten
may
caus
mild
sever
diarrhoea
contrast
fipv
infect
caus
chronic
often
fatal
pleuritisperiton
import
caus
death
infecti
origin
cat
two
form
fip
exist
effus
wet
form
typic
effus
bodi
caviti
less
common
noneffus
dri
form
characterist
lesion
form
granuloma
surfac
target
tissu
despit
larg
biolog
differ
genom
ident
fipv
fecv
isol
environ
therefor
propos
fipv
aris
fecv
mutat
exact
mutat
induc
factor
yet
clarifi
main
differ
fecv
fipv
invas
natur
fipv
fecv
replic
mainli
local
enterocyt
intestin
wherea
fipv
also
infect
blood
monocyt
spread
system
reason
pathogen
differ
understood
infiltr
infect
monocyt
perivascular
tissu
infect
monocyt
surround
cell
releas
numer
chemotact
vasoact
factor
lead
vasodilat
increas
vascular
permeabl
attract
new
monocyt
area
infect
turn
outcom
inflammatori
reaction
characterist
vascul
caus
venul
leak
larg
amount
protein
rich
plasma
bodi
caviti
releas
progeni
viru
also
lead
format
virusantibodycompl
complex
concentr
around
small
venul
target
organ
complex
activ
inflamm
although
differ
fipv
fecv
clear
vivo
vitro
first
vitro
characteris
fipv
strain
fecv
strain
done
mckeirnan
et
al
crandel
felin
kidney
crfk
cell
found
similar
growth
curv
fipv
fecv
replic
fipv
fecv
also
studi
periton
macrophag
report
fecv
infect
fewer
macrophag
reach
lower
product
titr
fipv
vivo
relev
infect
studi
like
higher
perform
continu
cell
line
fipv
fecv
replic
cycl
never
studi
vivo
targetcarri
cell
fipv
felin
blood
monocyt
present
studi
present
vitro
replic
kinet
fipv
fecv
target
cell
fipv
blood
monocyt
found
replic
kinet
depend
origin
cell
differ
fipv
fecv
found
crfk
cell
virus
third
passag
fipv
strain
fecv
strain
crfk
cell
use
fecv
strain
obtain
american
type
cultur
collect
atcc
fipv
strain
kindli
provid
dr
egberink
utrecht
univers
netherland
polyclon
antibodi
origin
cat
infect
fipv
kindli
provid
dr
egberink
utrecht
univers
netherland
antibodi
purifi
biotinyl
accord
manufactur
instruct
amersham
bioscienc
buckinghamshir
uk
monoclon
antibodi
mab
recognis
respect
mand
nprotein
kindli
provid
dr
hohdatsu
kitasato
univers
japan
monocyt
marker
recognis
cd
purchas
veterinari
medic
research
develop
pullman
washington
usa
three
cat
nonspecif
breed
fcov
free
close
household
use
blood
donor
extens
infect
kinet
studi
seventeen
stray
cat
brought
clinic
small
anim
faculti
veterinari
medicin
ghent
univers
spf
cat
use
studi
distribut
infect
kinet
pattern
sex
felv
fiv
fcov
statu
cat
list
tabl
six
ml
blood
collect
heparin
uml
leo
zaventem
belgium
vena
jugulari
blood
mononuclear
cell
separ
ficollpaqu
pharmacia
biotech
ab
uppsala
sweden
follow
manufactur
instruct
mononuclear
cell
resuspend
gibco
brl
merelbek
belgium
medium
contain
fetal
bovin
serum
fb
mgml
glutamin
uml
penicillin
mgml
streptomycin
mgml
kanamycin
uml
heparin
mm
sodium
pyruv
nonessenti
aminoacid
gibco
brl
afterward
cell
seed
dish
cell
cultur
coat
nunc
roskild
denmark
concentr
cellsml
cultiv
c
co
nonadher
cell
remov
wash
dish
two
time
h
seed
adher
cell
consist
monocyt
assess
fluoresc
stain
monocyt
marker
crfk
cell
monocyt
inocul
fipv
strain
fecv
strain
multipl
infect
moi
h
incub
c
co
cell
wash
time
incub
medium
differ
time
point
post
inocul
cultur
medium
harvest
centrifug
g
min
supernat
use
determin
extracellular
viru
titr
cell
remov
well
scrape
ad
pellet
determin
intracellular
viru
titr
viru
releas
cell
freezethaw
cycl
sampl
store
c
titrat
intraand
extracellular
viru
titr
assess
tissu
cultur
infect
dose
assay
use
crfk
cell
fifti
percent
endpoint
calcul
accord
method
reed
muench
viru
inactiv
curv
determin
keep
cell
free
viru
medium
c
co
sampl
taken
differ
time
point
store
c
titrat
male
f
femal
b
test
plasma
sampl
snap
fiv
antibodyfelv
antigen
combo
test
idexx
c
ipma
antibodi
titer
three
independ
assay
carri
inactiv
curv
calcul
linear
regress
differ
time
point
post
inocul
cell
seed
glass
coverslip
fix
formaldehyd
surfaceexpress
viral
protein
label
biotinyl
antifipv
polyclon
cat
antibodi
streptavidinfitc
molecular
probe
eugen
oregon
usa
permeabilis
triton
sigmaaldrich
gmbh
steinheim
germani
cytoplasm
viral
protein
stain
mixtur
monoclon
antibodi
goat
antimousetexa
red
molecular
probe
final
glass
coverslip
mount
microscop
slide
use
glycerinpb
solut
volvol
octan
janssen
chimica
beers
belgium
analys
fluoresc
microscopi
stray
cat
spf
cat
cytoplasm
viral
protein
stain
fitc
label
antifipv
antibodi
vmrd
inc
pullman
washington
usa
sampl
stain
visualis
cytoplasm
surfaceexpress
viral
protein
describ
examin
leica
tc
laser
scan
spectral
confoc
system
leica
microsystem
gmbh
wetzlar
germani
link
dm
irb
invert
microscop
leica
microsystem
argon
heliumneon
laser
light
use
excit
fitc
nm
line
texasr
nm
line
fluorochrom
imag
obtain
process
leica
confoc
softwar
experi
repeat
time
area
curv
calcul
experi
triplic
assay
compar
use
mannwithney
u
test
statist
analysi
perform
spss
spss
inc
chicago
illinoi
usa
growth
curv
fipv
fecv
crfk
cell
given
fig
product
progeni
viru
start
hpi
increas
strongli
hpi
hpi
slight
increas
viru
titr
reach
maximum
log
tcid
cell
hpi
signific
differ
growth
curv
fipv
fecv
growth
curv
fipv
fecv
monocyt
vari
differ
donor
cat
figur
show
product
fipv
start
h
post
inocul
cat
h
post
inocul
slight
increas
viru
titr
cat
wherea
curv
cat
fig
growth
curv
cat
fecv
show
lowlevel
product
fig
growth
curv
cat
fecv
began
slight
titr
increas
similar
fipv
growth
curv
viru
titr
decreas
slope
compar
inactiv
curv
fig
find
suggest
monocyt
could
infect
fecv
cell
sustain
product
infect
figur
show
growth
curv
cat
follow
inactiv
curv
suggest
progeni
viru
produc
fig
lane
show
larger
amount
surfaceexpress
viral
protein
fig
lane
antigen
express
kinet
vari
donor
cat
figur
f
show
fipv
fecv
cytoplasm
express
kinet
cat
percentag
fipv
infect
cell
cytoplasm
express
increas
till
hpi
infect
monocyt
fecv
initi
manner
hpi
curv
start
declin
cytoplasm
express
monocyt
cat
shown
fig
f
infect
fipv
fecv
led
express
kinet
increas
till
h
post
inocul
percentag
cell
viral
express
decreas
rapidli
number
fecv
infect
monocyt
lower
fipvinfect
monocyt
fipv
fecv
surfac
express
cat
follow
curv
cytoplasm
fig
h
fig
h
result
cat
quit
differ
cat
viral
antigen
posit
monocyt
found
know
total
product
infecti
progeni
viru
number
infect
cell
calcul
fipvinfect
monocyt
cat
produc
approxim
infecti
virus
per
infect
cell
h
post
inocul
fecvinfect
monocyt
cat
produc
time
less
progeni
viru
h
post
inocul
wherea
fecvinfect
monocyt
cat
produc
amount
progeni
viru
fipinfect
monocyt
order
clarifi
preval
pattern
viral
replic
observ
studi
bigger
cat
popul
antigen
express
kinet
studi
stray
cat
spf
cat
fipv
fecv
antigen
express
visualis
hour
post
inocul
result
present
fig
differ
express
kinet
found
monocyt
close
household
cat
also
seen
monocyt
stray
cat
spf
cat
within
popul
cat
monocyt
isol
cat
show
continu
increas
viral
antigen
posit
cell
hour
time
span
inocul
fipv
monocyt
inocul
fecv
number
viral
antigen
posit
cell
increas
hour
post
inocul
diminish
monocyt
cat
percentag
fipvand
fecvinfect
cell
increas
hpi
decreas
monocyt
cat
resist
infect
studi
vitro
infect
kinet
fipv
strain
fecv
strain
establish
peripher
blood
monocyt
cat
cat
close
household
stray
cat
spf
cat
first
time
infect
studi
perform
peripher
blood
monocyt
hostcarri
cell
fipv
three
distinct
pattern
found
infect
studi
monocyt
cat
infect
either
strain
first
pattern
reason
insuscept
cell
yet
clear
viru
particl
detect
cell
shortli
inocul
cell
product
viral
antigen
observ
use
polyclon
antibodi
data
shown
thu
seem
new
viral
protein
form
suggest
block
infect
locat
entri
viru
translat
step
vivo
resist
fipv
infect
observ
experiment
inocul
inocul
lethal
dose
fipv
vari
part
cat
depend
experi
show
clinic
sign
remain
seroneg
also
seen
control
group
vaccin
trial
vaccin
fipv
challeng
resist
fcov
infect
also
suggest
occur
natur
infect
field
small
percentag
cat
fcov
endem
household
shed
remain
seroneg
low
antibodi
titr
time
period
year
would
interest
investig
correl
vitro
vivo
resist
fcov
might
give
perspect
select
cat
insuscept
fip
monocyt
cat
show
increas
fipv
antigen
posit
cell
till
hpi
wherea
amount
fecv
antigen
posit
cell
drop
hpi
show
fipv
infect
sustain
wherea
fecv
infect
sustain
second
pattern
monocyt
cat
sustain
fipv
fecv
infect
sinc
number
viral
antigen
posit
cell
drop
hpi
third
pattern
drop
antigen
posit
cell
hour
post
inocul
may
explain
fact
infect
cell
die
due
infect
wash
away
stain
howev
kinet
found
stain
suspens
techniqu
prevent
cell
loss
data
shown
anoth
explan
monocyt
stop
produc
viral
protein
assembl
new
virion
extracellular
viru
titr
show
inde
almost
new
progeni
viru
produc
hour
post
inocul
graph
show
differ
viru
titr
experi
viru
monocyt
donor
cat
log
unit
differ
intrins
work
primari
cell
report
viral
infect
studi
porcin
equin
monocyt
well
although
fecv
initi
infect
monocyt
infect
never
sustain
implic
fecv
might
reach
blood
circul
vivo
sever
studi
healthi
cat
fcov
endem
household
investig
household
fcov
like
fecv
part
healthi
cat
viraem
fcov
fcov
detect
plasma
monocyt
therefor
may
hypothesis
fecv
reach
blood
circul
lack
sustain
longterm
product
progeni
viru
total
viru
product
time
lower
fecvinfect
monocyt
may
reason
lack
diseas
progress
might
form
basi
differ
fipv
sinc
fipv
infect
sustain
reach
higher
titr
howev
nonsustain
fecv
infect
might
also
attribut
viru
strain
use
although
fecv
refer
strain
may
act
differ
fecv
strain
due
delet
orf
describ
loss
orf
result
loss
virul
could
loss
virul
translat
loss
abil
replic
effici
monocyt
thu
whether
hamper
replic
strain
monocyt
univers
properti
fecv
strain
deletedmut
strain
remain
determin
differ
fipv
infect
kinet
depend
cat
monocyt
isol
suggest
cellular
factor
influenc
genet
background
andor
differentiationactiv
statu
import
determin
outcom
fipv
infect
infect
kinet
studi
anoth
cell
type
felin
periton
macrophag
use
differ
result
antigen
express
kinet
obtain
number
fecv
infect
periton
macrophag
lower
number
fipv
infect
periton
macrophag
throughout
infect
kinet
sinc
viral
antigen
kinet
perform
till
hour
post
inocul
possibl
drop
antigen
express
like
report
could
evalu
contrast
result
suggest
fipv
fecv
initi
infect
amount
cell
h
post
inocul
differ
sustain
infect
promin
sinc
virus
use
studi
differ
result
probabl
due
cellular
factor
andor
differ
differenti
statu
cell
differ
suscept
depend
differenti
andor
activ
statu
monocytesmacrophag
report
differ
virus
porcin
reproduct
respiratori
syndrom
viru
caprin
arthritisenceph
viru
suid
herp
viru
herp
simplex
viru
human
immunodefici
viru
type
maedivisna
viru
differ
activ
statu
might
explain
discrep
result
stoddart
scott
variat
suscept
sustain
mean
pathogenesi
fecv
fipv
vivo
remain
elucid
inocul
studi
use
fipv
differ
pattern
diseas
progress
detect
base
upon
surviv
time
progressor
rapid
intermedi
delay
survivor
prolong
longterm
natur
vivo
fcov
infect
differ
clinic
outcom
besid
resist
fcov
describ
persist
carrier
transient
infect
develop
fip
clear
viral
host
factor
determin
differ
clinic
outcom
sinc
inocul
studi
strain
use
consid
fact
field
cat
often
infect
strain
fcov
like
genom
variat
cat
contribut
differ
clinic
outcom
genet
background
also
suggest
field
studi
purebr
cat
shown
suscept
fip
inde
inherit
possibl
explan
differ
diseas
progress
possibl
cat
develop
effici
tcell
respons
howev
could
also
suscept
monocyt
fipv
play
role
consid
result
present
would
interest
investig
cat
show
differ
outcom
experiment
natur
infect
also
show
differ
infect
kinet
vitro
might
import
sinc
correl
vitro
vivo
infect
kinet
would
allow
easi
screen
select
studi
shown
viral
protein
express
surfac
fcov
infect
cell
howev
part
infect
cell
show
surfaceexpress
viral
antigen
hpi
infect
crfk
cell
infect
monocyt
show
surfaceexpress
viral
antigen
sand
mprotein
nprotein
found
cell
surfac
crfk
cell
monocyt
use
specif
monoclon
antibodi
data
shown
indic
observ
surfac
express
repres
viru
particl
possibl
explan
observ
differ
amount
surfaceexpress
viral
antigen
could
retent
part
viral
protein
spontan
internalis
surfaceexpress
viral
antigen
retent
viral
protein
describ
porcin
coronaviru
spontan
internalis
viral
protein
describ
suid
herp
viru
presenc
viral
antigen
cell
surfac
import
recognit
elimin
infect
cell
immun
system
bind
virusspecif
antibodi
viral
protein
present
surfac
make
infect
cell
recognis
classic
complement
pathway
phagocyt
natur
killer
cell
lead
lysi
infect
cell
interestingli
fipvand
fecvinfect
monocytesmacrophag
show
surfac
express
absenc
viral
protein
cell
surfac
describ
virus
human
cytomegaloviru
equin
herpesviru
strategi
avoid
recognit
antibodydepend
immun
respons
half
infect
cell
show
surfac
express
whether
cell
without
surfac
express
inde
less
suscept
toward
antibodydepend
complement
mediat
lysi
remain
elucid
fip
research
crfk
cell
line
often
use
perform
vitro
experi
result
studi
reveal
crfk
cell
line
best
suitabl
vitro
model
studi
fipv
fecv
replic
cellular
level
firstli
cours
infect
fipv
fecv
similar
crfk
cell
wherea
monocyt
clear
differ
vivo
secondli
high
percentag
infect
cell
reach
crfk
cell
inocul
cell
cell
produc
releas
rel
small
amount
infecti
viru
virusescel
monocyt
hand
less
cell
infect
singl
fipvinfect
monocyt
releas
new
infecti
virus
thirdli
crfk
cell
show
surfac
express
almost
infect
cell
contrast
monocyt
show
surfac
express
half
infect
cell
conclus
state
fcov
infect
kinet
vitro
strongli
depend
cellular
factor
monocyt
cat
infect
monocyt
suscept
fcov
infect
fipv
fecv
infect
howev
fecv
infect
never
sustain
product
viral
antigen
progeni
viru
ceas
h
post
inocul
sustain
fipv
infect
depend
origin
host
cell
fipv
product
suscept
monocyt
alway
time
higher
fecv
product
variat
suscept
sustain
implic
develop
pathogenesi
fip
andor
fecv
vivo
remain
elucid
